Soros Fund Management’s Boston Scientific BSX Stock Holding History

Soros Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$10.1M	–	215
2025 Q1	$10.1M	Hold	100,000	–	–	0.15%	133
2024 Q4	$8.93M	Sell	100,000 -250,001	-71%	-$22M	0.13%	125
2024 Q3	$29.3M	Buy	350,001 +100,000	+40%	+$7.88M	0.42%	55
2024 Q2	$19.3M	Buy	+250,001	New	+$18.3M	0.35%	74

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Soros Fund Management's BSX Position: Q2 2025 in Review

Soros Fund Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 100,000 shares — an estimated $10.1M sold.

Soros Fund Management first reported a position in BSX in Q2 2024 and held it in 4 quarters. The position peaked at $29.3M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Soros Fund Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Soros Fund Management sold 100,000 Boston Scientific shares in Q2 2025, an estimated $10.1M.
Soros Fund Management first reported a position in Boston Scientific in Q2 2024 and held it in 4 quarters.
Soros Fund Management's Boston Scientific position peaked at $29.3M in Q3 2024.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Soros Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.